Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lennon R et al. - Rosiglitazone has a direct and protective effect on glucose uptake in wild-type human podocytes. This represents a novel mechanism by which PPAR-gamma agonists may improve podocyte function in diabetic nephropathy.


Exclusive Author Commentary
M. A. Saleem, 06/23/09

The podocyte is increasingly being seen as central to the pathogenesis of diabetic nephropathy. Insulin sensitivity in glomerular podocytes is a novel and important finding in the context of understanding the pathogenesis of diabetic nephropathy. A key question is whether this cellular insulin sensitivity is lost in type II diabetes, as is seen in other insulin sensitive tissues, and therefore whether drugs can improve this sensitivity. This study for the first time demonstrates that podocytes can become insulin resistant, and that the PPARgamma class of drugs counteracts the effect, and in themselves improve podocyte insulin sensitivity.

Today in Glomerular/Tubular Dz...keeping you current

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09

Change in Estimated GFR Associates with Coronary Heart Disease and Mortality
Journal of the American Society of Nephrology, 11/23/09

Biomarkers for Lupus Nephritis: The Quest Continues
Clinical Journal of the American Society of Nephrology, 11/13/09

Today in Nephropathies...keeping you current

Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09

Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes
Clinical Journal of the American Society of Nephrology, 11/05/09

Renal artery stenosis: pathophysiology and treatment
Expert Review of Cardiovascular Therapy , 11/18/09

Today in Pharmacology/kinetics...keeping you current

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address